SCHEMBL22454130

SCHEMBL22454130

CN1N=CC[C@H]1C(C)(C)C

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ RIPK1 Q13546 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17244863 1.00 RIPK1 (0.31) RIPK1
SCHEMBL13967287 0.74 — —
SCHEMBL18806997 0.69 — —
SCHEMBL25080563 0.65 — —
SCHEMBL25468125 0.62 — —
SCHEMBL22795970 0.56 RIPK1 (0.31) RIPK1
SCHEMBL5281962 0.54 — —
SCHEMBL24448925 0.54 — —
SCHEMBL17738289 0.54 — —
SCHEMBL25453787 0.53 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020190754-A1 MACROCYCLIC AZOLOPYRIDINE DERIVATIVES AS EED AND PRC2 MODULATORS Fulcrum Therapeutics, Inc. (US) 2020-09-24 — — WO disclosed
Send feedback